The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of an objective scoring system on initiation of therapy in patients with International Neuroblastoma Risk Group Staging System (INRGSS) stage MS neuroblastoma: A report from the Children’s Oncology Group.
 
Leonora R. Slatnick
No Relationships to Disclose
 
Navin Pinto
Consulting or Advisory Role - Eureka Therapeutics; Novartis
Patents, Royalties, Other Intellectual Property - I hold a patent 20210346431 that has been licensed to Umoja Biotherapeutics and may result in royalty payments. No payments have been received to date.
(OPTIONAL) Uncompensated Relationships - US WorldMeds; Y-mAbs Therapeutics
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Jed G. Nuchtern
No Relationships to Disclose
 
Edward F. Attiyeh
No Relationships to Disclose
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb/Celgene
 
Clare Twist
No Relationships to Disclose
 
Meredith S. Irwin
No Relationships to Disclose
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
John M. Maris
No Relationships to Disclose
 
Mary Lou Schmidt
No Relationships to Disclose
 
Araz Marachelian
Consulting or Advisory Role - US World; Ymabs Therapeutics Inc
Research Funding - Pfizer (Inst); United Therapeutics (Inst)
 
Michael Brannon Armstrong
No Relationships to Disclose
 
Peter E. Zage
Consulting or Advisory Role - Y-mAbs Therapeutics
Research Funding - Aptose Biosciences; Boundless Bio; Exelixis; QED Therapeutics
 
Christopher Bertero Weldon
No Relationships to Disclose
 
Julie R. Park
Patents, Royalties, Other Intellectual Property - Patent licensed to Umoja Pharmaceuticals, no monetary value to date
 
Holly Jane Meany
No Relationships to Disclose